The IMPRINT network recently produced the animation resource below explaining Group B Strep vaccines aimed at a general audience. They will also be translating the video into other languages available in 2023.
For more IMPRINT GBS videos please visit https://www.imprint-network.co.uk/videos.
Maternal colonization by Group B Streptococcus (GBS) can lead to severe infection in neonates and has also been associated with prematurity and stillbirth. Bronner P. Gonçalves’s comments on research into maternal Group B Strep colonisation. Read more…
Vaccinating pregnant mothers could avert 31,000 deaths and save $385m in healthcare costs, it is estimated; A global maternal immunisation programme for group B Streptococcus – Strep B – would save millions of dollars in Read more…
MinervaXApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces the successful completion of a 72 million EUR financing round. The equity financing of 22 million EUR Read more…
0 Comments